AAX Biotech strengthens Board of Directors
Swedish biotech company AAX Biotech AB has welcomed Patrik Strömberg as a new member of the Board of Directors.
New Board Member at biotech start-up AAX Biotech, Patrik Strömberg, brings more than two decades of extensive experience in the pharmaceutical industry and a solid background in research and development, innovation management and business development. He has extensive experience from key positions at pharmaceutical companies such as AstraZeneca and Biovitrum/Sobi. Strömberg has been CEO of AnaCardio since 2021. He holds a PhD in biochemistry from Karolinska Institutet and an MBA from Stockholm University. AAX Biotech was founded by experts from Karolinska Institutet in Stockholm, Sweden.
Photo from Giulia Bertelli on Unsplash 
Engitix
Evotec SE